Other major exclusion criteria included a history of hypersensitivity to statin therapy, current active liver disease [liver transaminases (ALT or AST) > 1.5 times the upper limit of normal (ULN), or serum creatine kinase > 1.5 3 ULN]. Here, GPT is linked to liver disorder.